다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
미국
AMEX
Perspective Therapeutics Inc (CATX)
Perspective Therapeutics Inc (CATX) 뉴스

CATX

Perspective Therapeutics (CATX)

Perspective Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:AMEX:CATX

1 2 3 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/01/24	21:26	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:CATX	Perspective Therapeutics Inc
2025/01/24	21:00	GlobeNewswire Inc.	Perspective Therapeutics Continues to Pursue Dose Escalation of [212Pb]VMT-α-NET in its Ongoing Phase 1/2a Clinical Trial Based on Updated Interim Data Presented at the 2025 ASCO Gastrointestinal Cancers Symposium	AMEX:CATX	Perspective Therapeutics Inc
2025/01/22	21:00	GlobeNewswire Inc.	Perspective Therapeutics to Discuss Data on [212Pb]VMT-α-NET to be Presented at the ASCO Gastrointestinal Cancers Symposium on January 24, 2025	AMEX:CATX	Perspective Therapeutics Inc
2025/01/13	22:36	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:CATX	Perspective Therapeutics Inc
2025/01/13	22:00	GlobeNewswire Inc.	Perspective Therapeutics Provides Business Updates and Strategic Priorities Ahead of Presentation at 43rd Annual J.P. Morgan Healthcare Conference	AMEX:CATX	Perspective Therapeutics Inc
2025/01/10	21:00	GlobeNewswire Inc.	Perspective Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference	AMEX:CATX	Perspective Therapeutics Inc
2025/01/08	06:50	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	AMEX:CATX	Perspective Therapeutics Inc
2025/01/08	06:48	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	AMEX:CATX	Perspective Therapeutics Inc
2025/01/06	22:05	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:CATX	Perspective Therapeutics Inc
2025/01/06	22:00	GlobeNewswire Inc.	Perspective Therapeutics Appoints Juan Graham, MBA as Chief Financial Officer	AMEX:CATX	Perspective Therapeutics Inc
2024/12/07	06:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	AMEX:CATX	Perspective Therapeutics Inc
2024/12/05	07:20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	AMEX:CATX	Perspective Therapeutics Inc
2024/12/05	07:17	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	AMEX:CATX	Perspective Therapeutics Inc
2024/12/05	07:15	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	AMEX:CATX	Perspective Therapeutics Inc
2024/11/27	21:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	AMEX:CATX	Perspective Therapeutics Inc
2024/11/27	21:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	AMEX:CATX	Perspective Therapeutics Inc
2024/11/27	21:00	GlobeNewswire Inc.	Perspective Therapeutics to Participate in Upcoming Investor Conferences in December	AMEX:CATX	Perspective Therapeutics Inc
2024/11/26	21:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	AMEX:CATX	Perspective Therapeutics Inc
2024/11/21	21:30	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:CATX	Perspective Therapeutics Inc
2024/11/21	21:15	GlobeNewswire Inc.	Perspective Therapeutics to Pursue Dose Escalation of [212Pb]VMT-α-NET in its Ongoing Phase 1/2a Clinical Trial Based on Data Presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium	AMEX:CATX	Perspective Therapeutics Inc
2024/11/16	06:08	GlobeNewswire Inc.	Perspective Therapeutics to Discuss Data on [212Pb]VMT-α-NET Presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium on November 21, 2024	AMEX:CATX	Perspective Therapeutics Inc
2024/11/15	21:30	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:CATX	Perspective Therapeutics Inc
2024/11/15	08:14	Edgar (US Regulatory)	Form SC 13G - Statement of Beneficial Ownership by Certain Investors	AMEX:CATX	Perspective Therapeutics Inc
2024/11/15	06:05	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	AMEX:CATX	Perspective Therapeutics Inc
2024/11/15	00:24	Edgar (US Regulatory)	Form SC 13G - Statement of Beneficial Ownership by Certain Investors	AMEX:CATX	Perspective Therapeutics Inc
2024/11/13	06:11	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	AMEX:CATX	Perspective Therapeutics Inc
2024/11/13	06:07	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:CATX	Perspective Therapeutics Inc
2024/11/13	06:05	GlobeNewswire Inc.	Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal 3Q 2024 Results	AMEX:CATX	Perspective Therapeutics Inc
2024/10/31	20:00	GlobeNewswire Inc.	Perspective Therapeutics to Provide Business Highlights and Report Third Quarter 2024 Financial Results	AMEX:CATX	Perspective Therapeutics Inc
2024/10/29	20:00	GlobeNewswire Inc.	Perspective Therapeutics to Participate in Upcoming Investor Conferences in November	AMEX:CATX	Perspective Therapeutics Inc

검색 관련기사 보기:AMEX:CATX

1 2 3 다음 >>

Gold vs US Dollar

Energy Select Sector SPDR

Health Care Select Sector

BNP Paribas (QX)

US Dollar vs Euro

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관